Halozyme Therapeutics Inc logo

Halozyme Therapeutics Inc

NEW
NAS:HALO (USA)   Ordinary Shares
$ 77.81 +0.28 (+0.35%) 11:25 AM EST
27.99
P/B:
42.06
Market Cap:
$ 9.23B
Enterprise V:
$ 11.06B
Volume:
319.64K
Avg Vol (2M):
1.85M
Trade In:
Volume:
319.64K
Avg Vol (2M):
1.85M

Halozyme Therapeutics Inc (HALO) Dividend

Halozyme Therapeutics Inc (HALO) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of 4.5%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: HALO Dividend

Does Halozyme Therapeutics Inc (HALO) pay a dividend?

Halozyme Therapeutics Inc (HALO) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Halozyme Therapeutics Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Halozyme Therapeutics Inc has returned capital to shareholders via buybacks at a rate of 4.5% over the past 3 years.

What are dividend-paying alternatives to Halozyme Therapeutics Inc?

For dividend-paying alternatives in Halozyme Therapeutics Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.